Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 2.88p
   
  • Change Today:
      0.000p
  • 52 Week High: 6.25
  • 52 Week Low: 0.88
  • Currency: UK Pounds
  • Shares Issued: 4,766.44m
  • Volume: 320,409
  • Market Cap: £137.04m
  • RiskGrade: 268

Geographical - by origin

  30-Jun-1130-Jun-1030-Jun-0930-Jun-08
Revenue
Asian/an/an/an/a0.341%0.321%
Germany27.3966%29.9774%27.7273%20.6066%
North American/an/an/an/a0.892%3.3511%
Rest of Europe13.4632%10.2925%8.8023%6.7622%
UK0.702%0.491%n/an/an/an/a
Total 41.55100% 40.75100% 37.76100% 31.02100% 
 
Profit Before Tax
UK1.64n/a2.05n/an/an/an/an/a
Unanalysed(3.95)n/a(2.17)n/a(11.44)100%(20.24)100%
Total (2.31)n/a (0.12)n/a (11.44)100% (20.24)100% 

Geographical - by origin (turnover)

Product breakdown (turnover)

Product breakdown

  30-Jun-1130-Jun-1030-Jun-0930-Jun-08
Revenue
Milestonesn/an/an/an/a0.281%2.709%
Royalties1.113%2.025%1.835%1.856%
Sale of goods40.4497%38.7495%35.6494%26.4885%
Total 41.55100% 40.75100% 37.76100% 31.02100% 
 
Profit Before Tax
Unanalysed(2.31)n/a(0.12)n/a(11.44)n/a(20.24)n/a
Total (2.31)n/a (0.12)n/a (11.44)n/a (20.24)n/a 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page